PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2004
| PHARMANIAGA BERHAD |
|
Quarterly report for the financial period ended | 30/06/2004 |
| Quarter | 2 |
| Financial Year End | 31/12/2004 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2004 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2004 | 30/06/2003 | 30/06/2004 | 30/06/2003 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 178,644 | 155,262 | 369,949 | 309,787 |
| 2 | Profit/(loss) before tax | 16,264 | 13,347 | 36,933 | 31,260 |
| 3 | Profit/(loss) after tax and minority interest | 10,882 | 8,389 | 23,266 | 20,035 |
| 4 | Net profit/(loss) for the period | 10,882 | 8,389 | 23,266 | 20,035 |
| 5 | Basic earnings/(loss) per share (sen) | 10.77 | 8.39 | 23.05 | 20.03 |
| 6 | Dividend per share (sen) | 4.50 | 3.50 | 4.50 | 3.50 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 2.3800 | 2.2200 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| The Board of Directors of Pharmaniaga Berhad recommends an interim tax exempt dividend of 4.5 sen per share (2003: tax exempt dividend of 3.5 sen per share). The dates of entitlement and payment will be announced at a later date. |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 6 Aug 2004 |
| Category | Financial Results |
| Reference No | CC-040803-62728 |